Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Berkshire Hathaway Inc.    BRK.A

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Berkshire Hathaway : Ackman apologizes for Valeant losses, calls bet a mistake

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/30/2017 | 02:13am CEST
William Ackman speaks during the Sohn Investment Conference in New York

Billionaire hedge fund manager William Ackman has apologized to clients for betting on Valeant Pharmaceuticals International Inc (>> Valeant Pharmaceuticals Intl Inc), telling them he was "deeply and profoundly sorry" for losing so much of their money on the investment.

Billionaire hedge fund manager William Ackman has apologized to clients for betting on Valeant Pharmaceuticals International Inc (>> Valeant Pharmaceuticals Intl Inc), telling them he was "deeply and profoundly sorry" for losing so much of their money on the investment.

Ackman decided to sell his entire Valeant position earlier this month, suffering a roughly $4 billion loss since having bought the stake in early 2015.. He called the investment a "huge mistake."

"My approach to mistakes is that I personally assume 100 percent of the responsibility on behalf of the firm," he wrote in the firm's annual letter released to clients on Tuesday evening and seen by Reuters on Wednesday.

The 50-year-old manager acknowledged the toll the bad bet has taken on his image and said he misjudged the management team in place when he bought the stock.

"We deeply regret this mistake, which has cost all of us a tremendous amount," he wrote.

Thanks largely to Valeant's tumble, Ackman's hedge fund Pershing Square Capital Management suffered back-to-back losses in 2015 and 2016 as his reputation as one of the hedge fund industry's most talented investors dimmed.

Since launching the firm in 2004, Ackman has delivered a compound annual net return of 14.8 percent. He tends to take concentrated bets and often pushes management to perform better by urging spin-offs or other measures.

Nonetheless the board of Pershing Square Holdings, Ackman's publicly traded investment vehicle, decided after a review of his performance that he should continue to manage the investments, Anne Farlow, the chair, wrote in a separate letter.

She welcomed Ackman's openness in analyzing what led to the Valeant failure.

In his letter, Ackman laid some blame at the feet of Valeant's former management team, which he had thought was building the next Berkshire Hathaway (>> Berkshire Hathaway Inc.), once of the most profitable companies in the country.

Ackman met former Valeant Chief Executive Michael Pearson in 2014, when Pearson enlisted Ackman's help to try and buy Allergan and Pershing Square bought up Allergan shares to try and push that company's management into selling to Valeant.

Allergan ended up selling to a Actavis, netting Ackman his best-ever returns with his Pershing Square LP fund gaining 36.9 percent in 2014.

Ackman fired Pearson in 2016, however, after he got a seat on Valeant's board.

"Prior management substantially overpaid for the company's largest acquisition - its acquisition of Salix - which occurred contemporaneously with the substantial majority of our investment in the company," Ackman wrote.

Pershing Square Holdings has swung to losses of 2.5 percent after starting the year with gains, but Ackman promised a quick recovery in the letter to clients.

(Reporting by Svea Herbst-Bayliss; Editing by Lisa Shumaker and Tom Brown)

By Svea Herbst-Bayliss

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BERKSHIRE HATHAWAY INC.
02:13a BERKSHIRE HATHAWAY : Ackman apologizes for Valeant losses, calls bet a mistake
03/28 BERKSHIRE HATHAWAY : What buffett really thinks about passive funds
03/23 BERKSHIRE HATHAWAY : A.M. Best Affirms Credit Ratings of Berkshire Hathaway GUAR..
03/21 BERKSHIRE HATHAWAY : West Virginia worker wins BH bracket contest
03/21 Run, Don't Walk, to Buy Charlie Munger's Favorite Stock
03/20 BERKSHIRE HATHAWAY : IAG rebrands its Berkshire Hathaway Insurance Australia bus..
03/20 BERKSHIRE HATHAWAY : Specialty Insurance Launches Professional Firsttm Professio..
03/18 BERKSHIRE HATHAWAY : Count all costs because fees matter
03/17DJBERKSHIRE HATHAWAY : Salaries for Buffett, Munger Unchanged at $100,000 Each
03/17 BERKSHIRE HATHAWAY : Buffett's pay rises; Berkshire urges rejection of sharehold..
More news
Sector news : Property & Casualty Insurance - NEC
03/28DJSAMPO OYJ SAMPO PLC : Disclosure Under Chapter 9 Section 5 Of The Securities Mar..
03/27 Factbox - Impact on insurers from Britain's vote to leave the EU
03/27DJPICC PROPERTY & CASUALTY : 2016 Net Profit Down 18%
03/27DJPEOPLE INSURANCE OF CHINA : PICC 2016 Net Profit Down 27% at CNY14.25 Billion
03/24DJSAMPO OYJ SAMPO PLC : Disclosure Under Chapter 9 Section 5 Of The Securities Mar..
More sector news : Property & Casualty Insurance - NEC
News from SeekingAlpha
03/29 Does American Airlines Have 100% Upside?
03/28 Biglari Holdings - Buffett Imposter Or Investing Genius?
03/27 Transports Week In Review - It's Hiccup Time For Transports, As Broader Indic..
03/26 Learn From Warren Buffett's Diversification
03/24 The View From The Top
Advertisement
Financials ($)
Sales 2017 233 425 M
EBIT 2017 19 424 M
Net income 2017 18 507 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 22,44
P/E ratio 2018 20,45
Capi. / Sales 2017 1,78x
Capi. / Sales 2018 1,72x
Capitalization 415 229 M
More Financials
Chart BERKSHIRE HATHAWAY INC.
Duration : Period :
Berkshire Hathaway Inc. Technical Analysis Chart | BRK.A | US0846701086 | 4-Traders
Full-screen chart
Technical analysis trends BERKSHIRE HATHAWA...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 282 250 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Warren Edward Buffett Chairman & Chief Executive Officer
Marc D. Hamburg Chief Financial Officer & Senior Vice President
Charles Thomas Munger Vice Chairman
David Sanford Gottesman Independent Director
Walter Scott Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BERKSHIRE HATHAWAY INC..3.44%415 229
TRAVELERS COMPANIES IN..-0.51%34 066
TOKIO MARINE HOLDINGS ..0.31%32 990
ALLSTATE CORP10.48%29 900
SAMPO OYJ2.96%26 671
MS&AD INSURANCE GROUP ..0.77%21 079
More Results